Congenital myasthenic syndromes are a clinically and genetically heterogeneous group of hereditary disorders affecting neuromuscular transmission. We have identified mutations within the acetylcholine receptor (AChR) epsilon-subunit gene underlying congenital myasthenic syndromes in nine patients (seven kinships) of Dutch origin. Previously reported mutations epsilon1369delG and epsilonR311Q were found to be common; epsilon1369delG was present on at least one allele in seven of the nine patients, and epsilonR311Q in six. Phenotypes ranged from relatively mild ptosis and external ophthalmoplegia to generalized myasthenia. The common occurrence of epsilonR311Q and epsilon1369delG suggests a possible founder for each of these mutations originating in North Western Europe, possibly in Holland. Knowledge of the ethnic or geographic origin within Europe of AChR deficiency patients can help in targeting genetic screening and it may be possible to provide a rapid genetic diagnosis for patients of Dutch origin by screening first for epsilonR311Q and epsilon1369delG.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758211 | PMC |
| http://dx.doi.org/10.1007/s00415-009-5190-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulation of miR-206 in denervated and dystrophic muscles, and its effect on acetylcholine receptor clustering.
J Cell Sci
December 2024
Department of Molecular, Cellular and Developmental Biology, 1105 N. University Avenue, Ann Arbor, MI 48109, USA.
The muscle-specific microRNA miR-206 has recently emerged as a potential regulator of genes involved in the formation and regeneration of the neuromuscular junction (NMJ). This study investigated miR-206-3p (miR-206) expression in synaptic and non-synaptic regions of denervated mice and α-dystrobrevin (Dtna)-knockout mice, as well as its impact on the formation and/or maintenance of agrin-induced acetylcholine receptor (AChR) clusters. In denervated, Dtna-deficient and crushed muscles, miR-206 expression significantly increased compared to what was seen for innervated muscles.
View Article and Find Full Text PDFAnalysis of the neuromuscular deficits caused by STAM1 deficiency.
Curr Res Neurobiol
August 2024
Department of Neurobiology, Evelyn F. McKnight Brain Institute, Civitan International Research Center, University of Alabama at Birmingham, Birmingham, 35294, Alabama, USA.
The endosomal sorting complexes required for transport (ESCRT) pathway is composed of a series of protein complexes that are essential for sorting cargo through the endosome. In neurons, the ESCRT pathway is a key mediator of many cellular pathways that regulate neuronal morphogenesis as well as synaptic growth and function. The ESCRT-0 complex, consisting of HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) and STAM (signal-transducing adaptor molecule), acts as a gate keeper to this pathway, ultimately determining the fate of the endosomal cargo.
View Article and Find Full Text PDFCongenital Myasthenic Syndrome associated with acetylcholine receptor deficiency: case report and review of the literature.
Ophthalmic Genet
October 2024
Department of Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Introduction: Congenital Myasthenic Syndromes are a diverse group of conditions with a broad array of genetic underpinnings and phenotypic presentations. Acetylcholine receptor deficiency is one form that usually involves pathogenic variants in the Cholinergic Receptor Nicotinic Epsilon Subunit () gene encoding the ɛ-subunit of the acetylcholine receptor.
Methods: We report a case of a 4-year-old male with suspected Congenital Myasthenic Syndrome with Acetylcholine Receptor Deficiency who presented with ocular symptoms and generalized muscle weakness.
Advances in Understanding and Managing Myasthenia Gravis: Current Trends and Future Directions.
Cureus
April 2024
Physiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.
Article Synopsis
- Myasthenia gravis (MG) is an autoimmune disorder where the body's immune system creates antibodies against proteins crucial for muscle function, particularly affecting the receptors at the neuromuscular junction (NMJ).
- The disease leads to muscle weakness and fatigue, primarily impacting axial, respiratory, leg, and bulbar muscles, with symptoms often worsening over time.
- Treatment options include methods to remove harmful antibodies and manage symptoms, such as plasmapheresis and complement inhibition, and the condition can be associated with thymoma and other autoimmune diseases, highlighting the importance of immune system regulation.
"De Novo" Hypercapnic Respiratory Failure Unmasking Neuromuscular Disorders: Experiences From a Tertiary Care Center and Review of Literature.
J Clin Neuromuscul Dis
March 2024
The Brunei Neuroscience Stroke and Rehabilitation Center, Brunei, Darussalam.
Article Synopsis
- Neuromuscular disorders can affect respiratory function either early or late, and some patients may experience hypercapnic respiratory failure as the main issue, which complicates diagnosis.
- This study analyzed 27 patients with hypercapnic respiratory failure, finding that many had abnormal phrenic nerve function and diaphragm thickness, and established specific underlying conditions for each case.
- Results showed that a significant portion of patients experienced functional recovery, highlighting the importance of a systematic approach for early diagnosis and treatment in managing these cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!